Galanin and NPY, two peptides with multiple putative roles in the nervous system

Hormone and Metabolic Research

Volumn 31, Issue 5, 1999, Pages 330-334

  Hokfelt T ^a   Broberger, C ^a   Diez, M ^a   Xu, Z Q ^a   Shi, T ^a   Kopp, J ^a   Zhang, X ^a,b   Holmberg, K ^a   Landry, M ^a   Koistinaho, J ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Dept of Neurobiology ^*  (China)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Co Existence; Depression; DRG Neurons; Feeding; Neuropeptides; Pain

Indexed keywords

GALANIN; NEUROPEPTIDE Y;

CONFERENCE PAPER; DEPRESSION; FEEDING; HYPERPOLARIZATION; MOOD; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN; PRIORITY JOURNAL; SPINAL GANGLION;

ANIMALIA;

EID: 0032999895     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978748     Document Type: Conference Paper

References (48)

1. 1. Hökfelt T, Mutt V. Neuropeptides. In: Adelman G, Smith B (eds.) Encyclopedia of Neuroscience; Volume 2nd Edition. CD-ROM version. Amsterdam: Elsevier Sciences, 1997
2. 2. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS 1983; 164: 124-8
3. 3. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y, a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659-60
4. 4. Hökfelt T, Zhang X, Xu Z-Q, Ji R-R, Shi T, Corness J et al. Cellular and synaptic mechanisms in transition of pain from acute to chronic. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z (eds). Proceedings of the 8th World Congress in Pain, Progress in Pain Research and Management. Seattle: IASP Press, 1997; 8: 133-53
5. 5. Shehab SA, Atkinson ME. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons. Brain Res 1986; 372: 37-44
6. 6. Zhang X, Ju G, Elde R, Hökfelt T. Effect of peripheral nerve cut on neuropeptides in dorsal root ganglia and the spinal cord of monkey with special reference to galanin. J Neurocytol 1993; 22: 342-81
7. 7. Zhang X, Xu Z-Q, Shi T-J, Landry M, Holmberg K, Ju C et al. The regulation of expression of galanin and galanin receptors in dorsal root ganglia and spinal cord after axotomy and inflammation. Ann NY Acad Sci 1998; 863: 402-13
8. 8. Wiesenfeld-Hallin Z, Xu X-J, Langel Ü, Bedecs K, Hökfelt T, Bartfai T. Galanin-mediated control of pain: enhanced role after nerve injury. Proc Natl Acad Sci USA 1992; 89: 3334-7
9. 9. Verge VMK, Xu X-J, Langel Ü, Hökfelt T, Wiesenfeld-Hallin Z, Bartfai T. Evidence for an endogenous inhibitory control of autotomy, a behavioral sign of neuropathic pain, by galanin in the rat after sciatic nerve section: demonstrated by chronic intrathecal infusion of M-35, a newly developed high affinity galanin receptor antagonist. Neurosci Lett 1993; 149: 193-7
10. 10. Ji RR, Zhang Q, Bedecs K, Arvidsson J, Zhang X, Xu XJ et al. Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci USA 1994; 91: 12540-3
11. 11. Wiesenfeld-Hallin Z, Xu XJ, Villar MJ, Hökfelt T. Intrathecal galanin potentiates the spinal and analgesic effect of morphine: electrophysiological and behavioural studies. Neurosci Lett 1990; 109: 217-21
12. 12. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. TINS 1992; 15: 96-103
13. 13. Weihe E, Schäfer MK-H, Nohr D, Persson S. Expression of neuropeptides, neuropeptide receptors and neuropeptide processing enzymes in spinal neurons and peripheral non-neural cells and plasticity in models of inflammatory pain. In: Hökfelt T, Schaible H-G, Schmidt RF (eds). Neuropeptides, Nociception and Pain. London: Chapman and Hall 1994: 43-69
14. 14. White DM, Mansfield K. Vasoactive intestinal polypeptide and neuropeptide Y act indirectly to increase neurite outgrowth of dissociated dorsal root ganglion cells. Neuroscience 1996; 73: 881-7
15. 15. Verge VMK, Richardson PM, Wiesenfeld-Hallin Z, Hökfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: A novel role in peptide suppression in adult sensory neurons. J Neurosci 1995; 15: 2081-96
16. 16. Kerekes N, Landry M, Rydh-Rinder M, Hökfelt T. The effect of NGF, BDNF and bFGF on expression of galanin in cultured rat dorsal root ganglia. Brain Res 1997; 754: 131-41
17. 17. Fukada K. Purification and partial characterization of a cholinergic neuronal differentiation factor. Proc Natl Acad Sci USA 1985; 82: 8795-9
18. 18. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann MJ, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 1989; 246: 1412-6
19. 19. Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH et al. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 1993; 11: 1175-85
20. 20. Corness J, Shi T-J, Xu Z-Q, Brulet P, Hökfelt T. Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy. Exp Brain Res 1996; 112: 79-88
21. 21. Zigmond RE, Hyatt-Sachs H, Mohney RP, Schreiber RC, Shadiack AM, Sun Yet al. Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Presp Developm Neurobiol 1996; 4: 75-90
22. 22. Corness J, Stevens B, Douglas Fields R, Hökfelt T. NGF and LIF both regulated galanin gene expression in primary DRC cultures. Neuro Report 1998; 9: 1533-6
23. 23. Shadiack AM, Vaccariello SA, Sun Y, Zigmond RE. Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc Natl Acad Sci USA 1998; 95: 7727-30
24. 24. Everitt BJ, Meister B, Hökfelt T, Melander T, Terenius L, Rökaeus Å et al. The hypothalamic arcuate nucleus-median eminence complex: Immunohistochemistry of transmitters, peptides and DARPP-32 with special reference ro coexistence in dopamine neurons. Brain Res Rev 1986; 11: 97-155
25. 25. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987; 8: 256-87
26. 26. Frankish HM, Dryden S, Hopkins D, Qang Q, Williams G. Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolism. Peptides 1995; 4: 757-71
27. 27. Leibowitz SF. Brain peptides and obesity: pharmacological treatment. Obes Res 1995; 3: 573S-89S
28. 28. Kalra SP. Appetite and body weight regulation: is it all in the brain? Neuron 1997; 19: 227-30
29. 29. Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD. Regional distribution of putative NPY Y receptors and neurons expressing Y mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 1993; 5: 1622-37
30. 30. Zhang X, Bao L, Xu Z-Q, Kopp J, Arvidsson U, Elde R et al. Localization of neuropeptide YY1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons. Proc Natl Acad Sci USA 1994; 91: 11738-42
31. 31. Gustafson EL, Smith KE, Durkin MM, Walker MW, Gerald C, Weinshank R et al. Distribution of the neuropeptide YY2 receptor mRNA in rat central nervous system. Mol Brain Res 1997; 46: 223-35
32. 32. Broberger C, Landry M, Wong H, Walsh J, Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin and neuropeptide Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997b; 66: 393-408
33. 33. Fuxe K, Tinner B, Caberlotto L, Bunnemann B, Agnati LF. NPYY1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat. Neurosci Lett 1997; 225: 49-52
34. 34. Maltais LJ, Lane PW, Beamer WG. Anorexia, a recessive mutation causing starvation in preweanling mice. J Hered 1984; 75: 468-72
35. 35. Broberger C, Johansen J, Schalling M, Hökfelt T. Hypothalamic neurohistochemistry of the murine anorexia (anx/anx) mutation: Altered processing of neuropeptide Y (NPY) in the arcuate nucleus. J Comp Neurol 1997a; 387: 124-35
36. 36. Prusiner SB. Genetic and infectious prion diseases. Arch Neurol 1993; 50: 1129-53
37. 37. Schwarzer C, Sperk G, Samanin R, Rizzi M, Gariboldi M, Vezzani A. Neuropeptide-immunoreactivity and their mRNA expression in kindling: Functional implications for limbic epileptogenesis. Brain Res Rev 1996; 22: 27-50
38. 38. Diez M, Koistinaho J, DeArmond SJ, Camerino AP, Groth D, Caytano JC et al. Abberrant induction of neuropeptide Y mRNA in hippocampus CA3 pyramidal neurones in scrapie-infected mice. Neuro Report 1996; 7: 1887-92
39. 39. Diez M, Koistinaho J, DeArmond SJ, Groth D, Prusiner JB, Hökfelt T. Marked decrease of neuropeptide YY2 receptor binding sites in the hippocampus in murine prion disease. Proc Natl Acad Sci USA 1998; 94: 13267-72
40. 40. Colmers WF. Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann NY Acad Sci, NY 1990; 611: 206-218
41. 41. Dahlström A, Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand 1964; 62, Suppl 232: 1-55
42. 42. Whitaker-Azmitia PM, Peroutka SJ. The Neuropharmacology of Serotonin. Ann NY Acad Sci 1990: 600
43. 43. Melander T, Hökfelt T, Rökaeus A, Cuello AC, Oertel WH, Verhofstad A et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 1986; 6: 3640-54
44. 44. Cortés R, Ceccatelli S, Schalling M, Hökfelt T. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 1990; 6: 369-91
45. 45. Xu Z-QD, Zhang X, Pieribone VA, Grillner S, Hökfelt T. Galanin responses in rat dorsal raphe neurons: Electrophysiological and immunohistochemical studies with a note on galanin-R1 receptors. Neuroscience 1998; 87: 79-94
46. 46. Xu Z-QD, Shi T-JS, Hökfelt T. Galanin/GMAP-and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol 1998; 392: 227-51
47. 47. Pieribone V, Xu Z-Q, Zhang X, Grillner S, Bartfai T, Hökfelt T. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience 1995; 64: 861-74
48. 48. Morris JF, Pow DV, Sokol HW, Ward A. Dendritic release of peptides from magnocellular neurons in normal rats, Brattleboro rats and mice with hereditary nephrogenic diabetes insipidus. In: Gross P, Richter D, Robertson, GL Vasopressin. Paris: John Libbey Eurotext, 1993: 171-82